Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series
Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series. // Transplantation Proceedings. – URL: https://www.sciencedirect.com/science/article/pii/S0041134526003921?dgcid=rss_sd_all
Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series. Transplantation Proceedings. https://www.sciencedirect.com/science/article/pii/S0041134526003921?dgcid=rss_sd_all
“Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series.” Transplantation Proceedings.
@article{article108902,
title = {Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series},
journal = {Transplantation Proceedings},
url = {https://www.sciencedirect.com/science/article/pii/S0041134526003921?dgcid=rss_sd_all}
}